81 related articles for article (PubMed ID: 12624952)
21. Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium.
Lin B; White JT; Ferguson C; Wang S; Vessella R; Bumgarner R; True LD; Hood L; Nelson PS
Cancer Res; 2001 Feb; 61(4):1611-8. PubMed ID: 11245473
[TBL] [Abstract][Full Text] [Related]
22. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma.
Koksal IT; Dirice E; Yasar D; Sanlioglu AD; Ciftcioglu A; Gulkesen KH; Ozes NO; Baykara M; Luleci G; Sanlioglu S
Urol Oncol; 2004; 22(4):307-12. PubMed ID: 15283888
[TBL] [Abstract][Full Text] [Related]
23. Delineation of prognostic biomarkers in prostate cancer.
Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
[TBL] [Abstract][Full Text] [Related]
24. Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray.
Kim TM; Jeong HJ; Seo MY; Kim SC; Cho G; Park CH; Kim TS; Park KH; Chung HC; Rha SY
Clin Cancer Res; 2005 Jan; 11(1):79-86. PubMed ID: 15671531
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
26. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray.
Bull JH; Ellison G; Patel A; Muir G; Walker M; Underwood M; Khan F; Paskins L
Br J Cancer; 2001 Jun; 84(11):1512-9. PubMed ID: 11384102
[TBL] [Abstract][Full Text] [Related]
27. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
28. D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.
Kiessling A; Weigle B; Fuessel S; Ebner R; Meye A; Rieger MA; Schmitz M; Temme A; Bachmann M; Wirth MP; Rieber EP
Prostate; 2005 Sep; 64(4):387-400. PubMed ID: 15761874
[TBL] [Abstract][Full Text] [Related]
29. Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.
Lozano JJ; Soler M; Bermudo R; Abia D; Fernandez PL; Thomson TM; Ortiz AR
BMC Genomics; 2005 Aug; 6():109. PubMed ID: 16107210
[TBL] [Abstract][Full Text] [Related]
30. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
[TBL] [Abstract][Full Text] [Related]
31. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M
Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639
[TBL] [Abstract][Full Text] [Related]
32. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
Rauhala HE; Porkka KP; Tolonen TT; Martikainen PM; Tammela TL; Visakorpi T
Int J Cancer; 2005 Dec; 117(5):738-45. PubMed ID: 15981206
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of the annexin family protein family is associated with prostate cancer progression.
Xin W; Rhodes DR; Ingold C; Chinnaiyan AM; Rubin MA
Am J Pathol; 2003 Jan; 162(1):255-61. PubMed ID: 12507908
[TBL] [Abstract][Full Text] [Related]
34. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
35. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
36. Amplification and overexpression of prosaposin in prostate cancer.
Koochekpour S; Zhuang YJ; Beroukhim R; Hsieh CL; Hofer MD; Zhau HE; Hiraiwa M; Pattan DY; Ware JL; Luftig RB; Sandhoff K; Sawyers CL; Pienta KJ; Rubin MA; Vessella RL; Sellers WR; Sartor O
Genes Chromosomes Cancer; 2005 Dec; 44(4):351-64. PubMed ID: 16080200
[TBL] [Abstract][Full Text] [Related]
37. Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models.
Guo C; Wu G; Chin JL; Bauman G; Moussa M; Wang F; Greenberg NM; Taylor SS; Xuan JW
Mol Cancer Res; 2006 Dec; 4(12):957-69. PubMed ID: 17189386
[TBL] [Abstract][Full Text] [Related]
38. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
[TBL] [Abstract][Full Text] [Related]
39. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
